Memantine before mastectomy prevents post-surgery pain: A randomized, blinded clinical trial in surgical patients

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Morel, Véronique ^a   Joly, Dominique ^b   Villatte, Christine ^b   Dubray, Claude ^a,c,d   Durando, Xavier ^b   Daulhac, Laurence ^c,d   Coudert, Catherine ^a   Roux, Delphine ^a   Pereira, Bruno ^a   Pickering, Gisèle ^a,c,d  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b CENTRE JEAN PERRIN   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d U1107 Neuro Dol ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MEMANTINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; EMOTIONALITY; FEMALE; FOLLOW UP; HUMAN; MASTECTOMY; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN SEVERITY; PILOT STUDY; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TOTAL QUALITY MANAGEMENT; TREATMENT DURATION; TREATMENT RESPONSE; WELLBEING; ADVERSE EFFECTS; AGED; BREAST NEOPLASMS; MIDDLE AGED; PAIN, POSTOPERATIVE; SINGLE BLIND PROCEDURE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; MEMANTINE; MIDDLE AGED; PAIN, POSTOPERATIVE; PILOT PROJECTS; PLACEBOS; SINGLE-BLIND METHOD;

EID: 84962845381     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152741     Document Type: Article

References (56)

1. Edge SB. Advances in breast surgery, 2002-2012. J Natl Compr Canc Netw 2013;11(1):53-9. PMID: 23307981
2. Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br. J. Cancer 2005;92(2):225-30. PMID: 15655557
3. Dualé C, Ouchchane L, Schoeffler P; EDONIS Investigating Group, Dubray C. Neuropathic aspects of persistent postsurgical pain: a French multicenter survey with a 6-month prospective follow-up. J Pain. 2014 Jan; 15(1):24.e1-24.e20.
4. Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Moller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: Nationwide survey in Denmark. European Journal of Pain 2009;13:478-485. doi: 10.1016/j.ejpain. 2008.05.015 PMID: 18635381
5. Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br. J. Cancer 2005;92(2):225-30. PMID: 15655557
6. Golan-Vered Y, Pud D. Chemotherapy-induced neuropathic pain and its relation to cluster symptoms in breast cancer patients treated with paclitaxel. Pain Pract 2013;13(1):46-52. doi: 10.1111/j.1533-2500. 2012.00554.x PMID: 22533683
7. Hedayati E, Schedin A, Nyman H, Alinaghizadeh H, Albertsson M. The effects of breast cancer diagnosis and surgery on cognitive functions. Acta Oncol 2011;50(7):1027-36. doi: 10.3109/0284186X. 2011.572911 PMID: 21554027
8. Lindner OC, Phillips B, McCabe MG, Mayes A, Wearden A, Varese F, et al. Meta-Analysis of Cognitive Impairment Following Adult Cancer Chemotherapy. Neuropsychology 2014;28(5):726-40. doi: 10. 1037/neu0000064 PMID: 24635712
9. Denk F, McMahon SB, Tracey I. Pain vulnerability: a neurobiological perspective. Nat Neurosci 2014;17(2):192-200. doi: 10.1038/nn. 3628 PMID: 24473267
10. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010;85(3 Suppl):S3-14. doi: 10.4065/mcp. 2009.0649 PMID: 20194146
11. Pickering G, Pereira B, Clère F, Sorel M, De Montgazon G, Navez M, et al. Cognitive function in older patients with postherpetic neuralgia. Pain Pract 2014;14(1):E1-7. doi: 10.1111/papr.12079 PMID: 23701810
12. Cvrcek P. Side effects of ketamine in the long-term treatment of neuropathic pain. Pain Med 2008;9(2):253-257. doi: 10.1111/j.1526-4637.2007.00314.x PMID: 18298710
13. Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002;96(5):1053-1061. PMID: 11981142
14. Eisenberg E, Kleiser A, Dortort A, Haim T, Yarnitsky D. The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study. Eur. J. Pain 1998;2:321-327. PMID: 10700327
15. Nikolajsen L, Gottrup H, Anders GD, Jensen TS. Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: A randomized, double-blind, cross-over study. Anesth. Analg. 2000;91:960-966. PMID: 11004057
16. Maier C, Dertwinkel R, Mansourian N, Hosbach I, Schwenkreis P, Senne I, et al. Efficacy of the NMDAreceptor antagonist memantine in patients with chronic phantom limb pain-results of a randomized doubleblinded, placebo-controlled trial. Pain 2003;103:277-283. PMID: 12791434
17. Hackworth RJ, Tokarz KA, Fowler IM, Wallace SC, Stedje-Larsen ET. Profound pain reduction after induction of memantine treatment in two patients with severe phantom limb pain. Anesth. Analg. 2008;107:1377-1379. PMID: 18806054
18. Collins S, Sigtermans MJ, Dahan A, Zuurmond WW, Perez RS. NMDA receptor antagonists for the treatment of neuropathic pain. Pain Med 2010;11(11):1726-42. doi: 10.1111/j.1526-4637.2010. 00981.x PMID: 21044263
19. Wu LJ, Zhuo M. Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain. Neurotherapeutics 2009;6(4):693-702. doi: 10.1016/j.nurt.2009.07.008 PMID: 19789073
20. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009;10(9):895-926. doi: 10.1016/j.jpain. 2009.06.012 PMID: 19712899
21. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 2011;8(3):184-7. doi: 10.1038/nrclinonc.2010.227 PMID: 21364692
22. Terkawi AS, Sharma S, Durieux ME, Thammishetti S, Brenin D, Tiouririne M. Perioperative lidocaine infusion reduces the incidence of post-mastectomy chronic pain: a double-blind, placebo-controlled randomized trial. Pain Physician. Pain Physician. 2015 Mar-Apr; 18(2):E139-46. PMID: 25794212
23. Terkawi AS, Durieux ME, Gottschalk A, Brenin D, Tiouririne M. Effect of intravenous lidocaine on postoperative recovery of patients undergoing mastectomy: a double-blind, placebo-controlled randomized trial. Reg Anesth Pain Med. 2014 Nov-Dec; 39(6):472-7. PMID: 25275577
24. Lu TJ, Chen JH, Hsu HM, Wu CT, Yu JC. Efficiency of infiltration with bupivacain after modified radical mastectomy. Acta Chir Belg. 2011 Nov-Dec; 111(6):360-3. PMID: 22299320
25. Zielinski J, Jaworski R, Smietanska I, Irga N, Wujtewicz M, Jaskiewicz J. A randomized, double-blind, placebo-controlled trial of preemptive analgesia with bupivacaine in patients undergoing mastectomy for carcinoma of the breast. Med Sci Monit. 2011 Oct; 17(10):CR589-97. PMID: 21959614
26. Gómez-Hernández J, Orozco-Alatorre AL, Domínguez-Contreras M, Oceguera-Villanueva A, Gómez-Romo S, Alvarez Villaseñor AS, et al. Preoperative dexamethasone reduces postoperative pain, nausea and vomiting following mastectomy for breast cancer. BMC Cancer. 2010 Dec. 23;10:692. doi: 10. 1186/1471-2407-10-692 PMID: 21182781
27. Thienthong S, Krisanaprakornkit W, Taesiri W, Thaninsurat N, Utsahapanich S, Klaichanad C. Two doses of oral sustained-release tramadol do not reduce pain or morphine consumption after modified radical mastectomy: a randomized, double blind, placebo-controlled trial. J Med Assoc Thai. 2004 Jan; 87(1):24-32. PMID: 14971531
28. Morel V, Etienne M, Wattiez AS, Dupuis A, Privat AM, Chalus M, et al. Memantine, a promising drug for the prevention of neuropathic pain in rat. Eur. J Pharmacol 2013;721:382-390. doi: 10.1016/j.ejphar. 2013.06.020 PMID: 23810967
29. Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know. J Peripher Nerv Syst 2014;19(2):66-76. doi: 10.1111/jns5.12073 PMID: 24976572
30. Pickering G, Morel V, Joly D, Villatte C, Roux D, Dubray C, et al. Prevention of post-mastectomy neuropathic pain with memantine: study protocol for a randomized controlled trial. Trials 2014;15(1):331.
31. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-38. PMID: 8080219
32. Boureau F, Luu M, Doubrère JF. Comparative study of the validity of four French McGill Pain Questionnaire (MPQ) versions. Pain 1992;50(1):59-65. PMID: 1513604
33. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114(1-2):29-36. PMID: 15733628
34. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004;108(3):248-57. PMID: 15030944
35. Reitan RM, Wolfson D. The Halstead-Reitan Neuropshychological test battery: Therapy and clinical interpretation. Tucson, AZ: Neuropsychological Press. 1985.
36. Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203-14. PMID: 15010086
37. Crowe SF, Benedict T, Enrico J, Mancuso N, Matthews C, Wallace J. Cognitive Determinants of Performance on the Digit Symbol-Coding Test, and the Symbol Search Test of the Wais-III, and the Symbol Digit Modalities Test: An Analysis in a Healthy Sample. Aust. Psychol. 1999;34:204-210.
38. Parrott AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations, a review. Psychopharmacology 1980;71(2):173-9. PMID: 6777817
39. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83. PMID: 1593914
40. Leplège A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51(11):1013-23. PMID: 9817119
41. Pickering G, Pereira B, Dufour E, Soule S, Dubray C: Impaired modulation of pain in patients with postherpetic neuralgia. Pain Res Manag 2014;19:e19-e23. PMID: 24427769
42. Van Seventer R, Bach FW, Toth CC, Serpell M, Temple J, Murphy TK, et al. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial. Eur J Neurol 2010;17:1082-1089. doi: 10.1111/j.1468-1331.2010.02979.x PMID: 20236172
43. Vickers AJ, Altman DG: Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 2001;323:1123-1124. PMID: 11701584
44. Berthier M, Starkstein S, Leiguarda R. Asymbolia for pain: a sensory-limbic disconnection syndrome. Ann Neurol 1988;24(1):41-9. PMID: 3415199
45. Pickering G, Morel V, Simen E, Cardot JM, Moustafa F, Delage N, et al. Oral magnesium treatment in patients with neuropathic pain: a randomized clinical trial. Magnes Res 2011;24(2):28-35. doi: 10. 1684/mrh.2011.0282 PMID: 21659058
46. Lee I, Kesner RP. Differential contribution of NMDA receptors in hippocampal subregions to spatial working memory. Nat Neurosci 2002;5(2):162-8. PMID: 11780144
47. Wei F, Wang GD, Kerchner GA, Kim SJ, Xu HM, Chen ZF, et al. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 2001;4(2):164-9. PMID: 11175877
48. Li XY, Wang N, Wang YJ, Zuo ZX, Koga K, Luo F, et al. Long-term temporal imprecision of information coding in the anterior cingulate cortex of mice with peripheral inflammation or nerve injury. J Neurosci 2014;34(32):10675-87. doi: 10.1523/JNEUROSCI.5166-13.2014 PMID: 25100600
49. Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapyinduced cognitive changes in breast cancer patients. Support Care Cancer 2011;19:1647-1656. doi: 10.1007/s00520-010-0997-4 PMID: 20820813
50. Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol 2011;93(3):385-404. doi: 10.1016/j.pneurobio.2011.01.002 PMID: 21216272
51. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007;109(9):1905-13. PMID: 17351951
52. Downie FP, Mar Fan HG, Houédé-Tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology 2006;15(10):921-30. PMID: 16477674
53. Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br. J. Cancer. 2006;94(6):828-34. PMID: 16523200
54. Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D, et al. Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 2010;32(3):324-31. doi: 10.1080/13803390903032537 PMID: 19642048
55. Debess J, Riis J, Pedersen L, Ewertz M. Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark. Acta Oncol. 2009;48(4):532-40. doi: 10.1080/02841860802600755 PMID: 19096948
56. Pickering G, Gavazzi G, Gaillat J, Paccalin M, Bloch K, Bouhassira D. Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort study. BMJ Open. 2016 Feb. 18;6(2):e009689. doi: 10.1136/bmjopen-2015-009689 PMID: 26892790